[1] Lu FM, Zhuang H. Management of hepatitis B in China. Chin Med J (Engl), 2009,122:3-4.
[2] Song BC, Kim H, Kim SH, et al. Comparison of full length sequences of hepatitis B virus isolates in hepatocellular carcinoma patients and asymptomatic carriers of Korea. J Med Virol, 2005,75:13-19.
[3] Pollicino T, Zanetti AR, Cacciola I, et al. Pre-S2 defective hepatitis B virus infection in patients with fulminant hepatitis. Hepatology, 1997,26:495-499.
[4] 中华医学会肝病学分会,中华医学会感染病学分会. 慢性乙型肝炎防治指南 (2010 年版). 临床肝胆病杂志, 2011,27:113-128.
[5] 边中启, 华占楼, 严维耀, 等. 中国云南少数民族地区慢性乙型肝炎患者病毒基因型的鉴定. 中华医学杂志, 2006,86:681-686.
[6] Choi MS, Kim DY, Lee DH, et al. Clinical significance of pre-S mutations in patients with genotype C hepatitis B virus infection. J Viral Hepat, 2007,14:161-168.
[7] Yin J, Xie J, Zhang H, et al. Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma. J Gastroenterol, 2010,45:1063-1071.
[8] Wang HC, Wu HC, Chen CF, et al. Different types of ground glass hepatocytes in chronic hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. Am J Pathol, 2003,163:2441-2449.
[9] Hsieh YH, Su IJ, Wang HC, et al. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis, 2004,25:2023-2032.
[10] Mun HS, Lee SA, Jee Y, et al. The prevalence of hepatitis B virus preS deletions occurring naturally in Korean patients infected chronically with genotype C. J Med Virol, 2008,80:1189-1194. |
